Innovative Targeting Solutions Announces Research Agreement with Lilly

January 22, 2018
Innovative Targeting Solutions Inc.

Vancouver, BC – January 22, 2018 – Innovative Targeting Solutions Inc. (ITS) today announced a research agreement with Eli Lilly and Company. Under the agreement, Innovative Targeting Solutions’ will utilize its proprietary HuTARG™ research platform to potentially discover first in class antibody drug candidates. The HuTARG™ protein engineering platform allows one to directly isolate and … Continue reading Innovative Targeting Solutions Announces Research Agreement with Lilly

CQDM and Brain Canada Inject $1 M in Top BC Biotech Firm AbCellera to Advance Discovery Platform for Next-Generation Antibody Therapeutics

January 17, 2018
AbCellera Biologics Inc.

The program will leverage AbCellera’s high-throughput, single-cell screening platform to allow rapid identification of functional antibodies against complex membrane proteins.   MONTREAL, January 17th, 2018 – CQDM and Brain Canada are proud to announce the nondilutive funding of $1 M to AbCellera and the University of British Columbia. AbCellera will also contribute $450,000 to the project, … Continue reading CQDM and Brain Canada Inject $1 M in Top BC Biotech Firm AbCellera to Advance Discovery Platform for Next-Generation Antibody Therapeutics

Generator Challenge Competition 2018-19

January 15, 2018
Discovery Parks

January 15th, 2018 | DP News Technology startup company in need of professional office space?  The Generator Challenge competition awards 12 months of free furnished office space to startups deemed most-likely to succeed and grow.  Application deadline: February 9th, 2018. Discovery Parks and the City of Vancouver invite early-stage technology-based companies to apply to win … Continue reading Generator Challenge Competition 2018-19

CannaRoyalty and Aequus Pharmaceuticals Announce Joint Venture to Develop and Commercialize Cannabis-Based Therapies Targeting Neurological Disorders

January 11, 2018
Aequus Pharmaceuticals Inc.

CannaRoyalty to contribute Bodhi Research position into the JV in exchange for equity Ottawa, Canada – January 11, 2018 – CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) (“CannaRoyalty”) and Aequus Pharmaceuticals Inc. (TSX-V: AQS) (OTCQB: AQSZF) (“Aequus”) (together the “Partners”), today announced a collaboration (the “JV”) to advance a suite of cannabis-based therapies targeting neurological disorders … Continue reading CannaRoyalty and Aequus Pharmaceuticals Announce Joint Venture to Develop and Commercialize Cannabis-Based Therapies Targeting Neurological Disorders

MSFHR appoints Dr. Bev Holmes as President & CEO

January 10, 2018
Michael Smith Foundation for Health Research

The Michael Smith Foundation for Health Research (MSFHR) Board is pleased to announce that following an executive search process, Dr. Bev Holmes has been appointed as president and CEO. With an eight-year history of leadership within MSFHR, Bev is ideally suited to lead MSFHR as we grow our role as BC’s expert health research funding … Continue reading MSFHR appoints Dr. Bev Holmes as President & CEO

Phyton Biotech Unifies International Operations Under New Leadership

January 9, 2018
Phyton Biotech

Restructuring, Appointment of New President Supports Company Growth, Diversified Operations January 03, 2018 11:00 AM Eastern Standard Time VANCOUVER, Canada–(BUSINESS WIRE)–DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in health care, announced the promotion of Colin Marr to President of Phyton Ltd., the world’s … Continue reading Phyton Biotech Unifies International Operations Under New Leadership